17th Apr 2018 1:30 pm |
RNS |
Director/PDMR Shareholding |
17th Apr 2018 1:24 pm |
RNS |
Director/PDMR Shareholding |
17th Apr 2018 1:20 pm |
RNS |
Director/PDMR Shareholding |
13th Apr 2018 3:50 pm |
RNS |
Director/PDMR Shareholding |
13th Apr 2018 3:44 pm |
RNS |
Director/PDMR Shareholding |
13th Apr 2018 11:32 am |
RNS |
Notice of GM |
12th Apr 2018 3:04 pm |
RNS |
Director/PDMR Shareholding |
3rd Apr 2018 4:14 pm |
RNS |
Total Voting Rights |
29th Mar 2018 1:00 pm |
RNS |
Notice of AGM |
27th Mar 2018 7:00 am |
RNS |
GSK agrees to acquire CH business from Novartis |
23rd Mar 2018 11:21 am |
RNS |
ViiV - CHMP positive opinion for Juluca in Europe |
23rd Mar 2018 7:44 am |
RNS |
Update regarding Pfizer Inc. Consumer Healthcare |
23rd Mar 2018 7:00 am |
RNS |
Shingrix approved in Europe and Japan |
19th Mar 2018 7:00 am |
RNS |
GSK 2017 Form 20-F |
13th Mar 2018 2:10 pm |
RNS |
Annual Financial Report |
12th Mar 2018 4:30 pm |
RNS |
Director/PDMR Shareholding |
8th Mar 2018 8:00 am |
RNS |
GSK announces labelling update to Relvar Ellipta |
5th Mar 2018 5:01 pm |
RNS |
ViiV Healthcare announces new dolutegravir data |
5th Mar 2018 2:47 pm |
RNS |
Nucala OSMO study presented at AAAAI-WAO congress |
5th Mar 2018 12:04 pm |
RNS |
Director/PDMR Shareholding |
2nd Mar 2018 1:11 pm |
RNS |
Director/PDMR Shareholding |
1st Mar 2018 11:16 am |
RNS |
Total Voting Rights |
22nd Feb 2018 4:54 pm |
RNS |
Director/PDMR Shareholding |
20th Feb 2018 1:17 pm |
RNS |
Director/PDMR Shareholding |
20th Feb 2018 1:16 pm |
RNS |
Director/PDMR Shareholding |
20th Feb 2018 1:15 pm |
RNS |
Director/PDMR Shareholding |
19th Feb 2018 6:12 pm |
RNS |
Director/PDMR Shareholding |
16th Feb 2018 5:29 pm |
RNS |
Director/PDMR Shareholding |
16th Feb 2018 5:25 pm |
RNS |
Director/PDMR Shareholding |
16th Feb 2018 11:20 am |
RNS |
Director/PDMR Shareholding |
15th Feb 2018 6:09 pm |
RNS |
Director/PDMR Shareholding |
15th Feb 2018 5:57 pm |
RNS |
Director/PDMR Shareholding |
15th Feb 2018 5:53 pm |
RNS |
Director/PDMR Shareholding |
14th Feb 2018 9:00 am |
RNS |
GSK submits landmark IMPACT data - Trelegy Ellipta |
13th Feb 2018 4:44 pm |
RNS |
Director/PDMR Shareholding |
12th Feb 2018 2:43 pm |
RNS |
Director/PDMR Shareholding |
12th Feb 2018 12:47 pm |
RNS |
Director/PDMR Shareholding |
8th Feb 2018 9:31 am |
RNS |
ViiV Healthcare launches new two-drug HIV study |
8th Feb 2018 7:00 am |
RNS |
ViiV files patent infringement litigation |
7th Feb 2018 1:19 pm |
RNS |
Director/PDMR Shareholding |